Quest Diagnostics Inc
F:QDI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Q
|
Quest Diagnostics Inc
F:QDI
|
US |
|
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
UK |
|
C
|
Carlisle Companies Inc
DUS:CLE
|
US |
|
C
|
CRH PLC
F:CRG
|
IE |
|
I
|
IHI Corp
F:IWJ
|
JP |
|
A
|
Andlauer Healthcare Group Inc
TSX:AND
|
CA |
|
G
|
Genuine Parts Co
DUS:GPT
|
US |
|
E
|
EchoStar Corp
F:E20
|
US |
|
C
|
CTS Corp
XBER:XT1
|
US |
|
B
|
Bank of Nova Scotia
F:BKN
|
CA |
|
Innospec Inc
NASDAQ:IOSP
|
US |
|
S
|
SandRidge Energy Inc
F:SA2D
|
US |
Wall St Price Targets
QDI Price Targets Summary
Quest Diagnostics Inc
According to Wall Street analysts, the average 1-year price target for QDI is 186.92 EUR with a low forecast of 149.63 EUR and a high forecast of 212.64 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is QDI's stock price target?
Price Target
186.92
EUR
According to Wall Street analysts, the average 1-year price target for QDI is 186.92 EUR with a low forecast of 149.63 EUR and a high forecast of 212.64 EUR.
What is the Revenue forecast for Quest Diagnostics Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 5 years is 4%.
What is the Operating Income forecast for Quest Diagnostics Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 9%.
What is the Net Income forecast for Quest Diagnostics Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 5 years is 11%.
